Tumor-normal + MRD (ppmSeq®) dataset

The pursuit of rare variant detection is of paramount importance in oncology, particularly when examining Minimal Residual Disease (MRD) aiming to comprehend and monitor diseases at their most minuscule levels. Identifying these variants at extremely low allelic fraction not only informs clinicians about the efficacy of therapies but also serves as an early warning system, signaling the potential for disease recurrence.